Thyroid tablets recalled nationwide due to potential over-potency risk

Most Commonly Prescribed Thyroid Medication Recalled Over Potency Issues: FDA

More than a dozen lots of a commonly prescribed thyroid medication were recalled this month due to potency issues, according to an enforcement report published by the Food and Drug Administration this week. The recall impacts levothyroxine sodium tablets in different strengths contained in bottles of different counts, several FDA notices said. The medication was manufactured by India-based Intas Pharmaceuticals Limited for North Carolina-based A…

Thyroid tablets recalled nationwide due to potential over-potency risk

More than 3,600 bottles of a common thyroid medication are being recalled nationwide because lab testing showed the pills could be too strong.